Billiontoone’s (BLLN) “Buy” Rating Reiterated at Guggenheim

Guggenheim reaffirmed their buy rating on shares of Billiontoone (NASDAQ:BLLN) in a research report report published on Thursday,Benzinga reports. Guggenheim currently has a $120.00 price target on the stock.

A number of other research firms have also issued reports on BLLN. Wall Street Zen raised shares of Billiontoone to a “hold” rating in a research report on Saturday, November 15th. Jefferies Financial Group began coverage on shares of Billiontoone in a research note on Monday, December 1st. They issued a “hold” rating and a $117.00 price objective on the stock. JPMorgan Chase & Co. reduced their target price on shares of Billiontoone from $150.00 to $145.00 and set an “overweight” rating for the company in a report on Wednesday, December 10th. Piper Sandler restated an “overweight” rating on shares of Billiontoone in a research report on Wednesday, December 10th. Finally, Wells Fargo & Company started coverage on shares of Billiontoone in a report on Monday, December 1st. They issued an “equal weight” rating and a $110.00 price target on the stock. Six research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $129.57.

Billiontoone Trading Up 1.9%

Billiontoone stock opened at $73.51 on Thursday. The company’s 50-day moving average price is $85.55. The stock has a market cap of $3.36 billion and a P/E ratio of 735.10. Billiontoone has a fifty-two week low of $66.00 and a fifty-two week high of $138.70.

Billiontoone (NASDAQ:BLLN) last announced its quarterly earnings data on Wednesday, March 4th. The company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.07. The firm had revenue of $96.05 million during the quarter, compared to analysts’ expectations of $85.85 million. The business’s revenue for the quarter was up 113.0% compared to the same quarter last year.

Hedge Funds Weigh In On Billiontoone

Large investors have recently made changes to their positions in the company. Rossby Financial LCC purchased a new stake in Billiontoone during the fourth quarter worth $25,000. Wells Fargo & Company MN purchased a new position in Billiontoone in the fourth quarter valued at $76,000. Smartleaf Asset Management LLC acquired a new position in shares of Billiontoone in the fourth quarter worth about $80,000. Nano Cap New Millennium Growth Fund L P acquired a new stake in shares of Billiontoone during the 4th quarter valued at about $82,000. Finally, Renaissance Capital LLC purchased a new position in shares of Billiontoone in the 4th quarter valued at about $201,000.

Key Billiontoone News

Here are the key news stories impacting Billiontoone this week:

• Positive Sentiment: Q4 earnings beat and rapid revenue growth — BillionToOne reported $0.11 EPS vs. $0.04 consensus and revenue of $96.05M (vs. $85.85M est.), with revenue up ~113% year-over-year; results and commentary point to accelerating demand. View Press Release
• Positive Sentiment: Raised FY‑2026 revenue guidance — company lifted 2026 revenue guidance to $430M–$445M vs. consensus near $356M, implying materially stronger top‑line growth than analysts expected. Press Release
• Positive Sentiment: Earnings call & investor materials highlight strategy and growth drivers — management commentary and the slide deck underscored durable revenue expansion and product/market traction that support the raised guidance. Earnings Highlights
• Positive Sentiment: Analyst support: Guggenheim reaffirmed a “buy” with a $120 PT — another buy-side vote that can buoy sentiment despite mixed firm-level price target moves. Benzinga
• Positive Sentiment: Positive coverage piece framing BLLN as an attractive investment — broader bullish narratives and coverage can amplify buying interest following the beat and guidance lift. Article
• Neutral Sentiment: Analyst deep‑dive and metric comparisons — outlets (e.g., Zacks) are parsing metrics vs. estimates and prior periods; useful for modeling but not new catalyst. Zacks
• Neutral Sentiment: Q4 snapshot pieces summarize results for retail/institutional readers — helpful context but unlikely to move price independently. LMOnline
• Neutral Sentiment: Short‑interest data appears anomalous/unchanged (reports show zeros/NaN); no clear short squeeze signal from these feeds. (Data quality issue; monitor official FINRA reports.)
• Negative Sentiment: Wells Fargo cut its price target to $90 and set an “equal weight” rating — a downgrade in conviction from that shop could cap near‑term upside and weigh on sentiment for more conservative investors. Benzinga
• Negative Sentiment: BTIG trimmed its target from $160 to $140 (still a “buy”) — target cuts reduce the extent of analyst-driven upside, even if the rating remains positive. Street Insider

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.